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Abstract: Hemocompatibility is an essential prerequisite for the application of materials in the field
of biomedicine and biosensing. In addition, mixed ionic and electronic conductivity of conducting
polymers is an advantageous property for these applications. Heparin-like materials containing
sulfate, sulfamic, and carboxylic groups may have an anticoagulation effect. Therefore, sodium
dodecylbenzenesulfonate, 2-aminoethane-1-sulfonic acid andN-(2-acetamido)-2-aminoethanesulfonic
acid were used for modification of the representative of conducting polymers, polyaniline, and the
resulting products were studied in the context of interactions with human blood. The anticoagulation
activity was then correlated to surface energy and conductivity of the materials. Results show that
anticoagulation activity is highly affected by the presence of suitable functional groups originating
from the used heparin-like substances, and by the properties of polyaniline polymer itself.
Keywords: polymer conductivity; conducting polymer; polyaniline; hemocompatibility
1. Introduction
The hemocompatibility of any material is a crucial factor in its application in biomedicine,
regenerative medicine, or biosensors. The phenomenon of hemocompatibility is very complex and
comprises various processes of which blood coagulation remains at the center of attention when tissue
engineering and biosensing applications are considered. Any material that comes in contact with
blood should not induce coagulation either by disrupting physiological blood flow or by interactions
of the blood with the surface of a material on a molecular level.
In some special applications (e.g., biosensing or tissue engineering of electrosensitive tissues)
the conductivity of materials can be an advantage. However, common conducting materials (such
as metals or metal oxides) can induce an undesired reaction on contact with tissues (e.g., because
of their different elasticity compared to native tissue). Therefore, conducting polymers can be more
appropriate. Moreover, conducting polymers have a huge potential for the mentioned applications as
they show mixed ionic and electronic conductivity, which is preferred for electrically active biointerfaces.
The effect of conductivity on the biological systems is a comprehensive issue. We, therefore, refer to
the publication of Rivnay et al. [1], who discuss the topic of ionic and electronic conductivity in depth.
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Polypyrrole (PPy), poly(3,4-ethylenedioxythiophene) (PEDOT) and polyaniline (PANI) can be
considered as the most frequently studied conducting polymers. The biocompatibility of these
polymers was recently studied in many research works. For example, the Ramanaviciene et al. [2]
tested the effect of PPy particles on mouse peritoneum cells. The action of injected PPy particles was
dependent on their concentration and duration of treatment. Nevertheless, the amount of neutrophils
did not exceed the limit values at any of the particle concentrations used. Vaitkuviene et al. [3] also
investigated the effect of PPy nanoparticle concentration on living systems. It has been demonstrated
that PPy nanoparticles exhibit a cytotoxic effect on murine embryonic stem cells, murine hepatoma
cells, and human Jurkat T lymphocytes at concentrations higher than 19.4 µg·mL−1. From a practical
point of view, the polymer films are more important as regards bio applications. Vaitkuviene et al. [4]
coated gold-plated glass slides by PPy. Proliferation of mouse stem cells on the treated surfaces was
comparable to reference (tissue plastic). The PANI, which is the object of this work, was also previously
studied in the context of biocompatibility. Its biocompatibility and especially the cytotoxicity were
tested on pristine PANI salt and base [5], as well as on its globular and nanotubular forms [6]. In the
scientific literature, it is often mentioned that PPy exhibits favorable properties compared to PANI.
However, the study of Humpolícˇek et al. [7] dealing with the comparison of the biocompatibility of
PANI and PPy in terms of cytotoxicity and embryotoxicity showed that the form of polymer (salt vs.
base) is more important than its type (PPy vs. PANI). Likewise, the present study compares, inter alia,
two forms of PANI, salt and base.
The amounts of information found in the scientific literature about the hemocompatibility of
conducting polymer differ. Whilst PPy has been intensely studied, predominantly in functionalized
forms or as a part of composites, PEDOT or polyaniline has been investigated as possible biomaterials
but their hemocompatibility has not been studied. Li et al. [8] dealt with the blood compatibility of
PPy films functionalized by heparin. The compatibility was evaluated using plasma re-calcification
time and platelet adhesion. The results showed that, with immobilized heparin, platelet adhesion and
platelet activation on PPy films were significantly suppressed and, moreover, the plasma re-calcification
time was considerably prolonged.
Ferraz et al. [9] tested the hemocompatibility of nanocellulose/PPy membranes modified by a
stable heparin coating. The results demonstrated that the heparinized composites were comparable
with hemocompatible polysulfone regarding platelet adhesion and thrombin generation, whereas,
in terms of complement activation, they were more biocompatible than commercially available
membranes. Mao et al. [10] investigated O-butyryl chitosan-grafted PPy film for blood compatibility
using platelet-rich plasma. The surface with immobilized O-butyryl chitosan exhibited lower platelet
adhesion and fibrinogen adsorption compared to unmodified PPy. The films showed good blood
compatibility and high electrical conductivity.
Previously it was mentioned that the functionalization of neat PANI films with
poly(2-acrylamido-2-methyl-1-propanesulfonic acid) (PAMPSA) results in the hindering of blood
coagulation [11]. Humpolícˇek et al. [11] followed up the studies of Paneva et al. [12] and
Yancheva et al. [13] who have shown that PAMPSA can act against blood clotting in a similar
way as heparin, either alone or incorporated in copolymers. The biological activity of PAMPSA
was studied by Šorm et al. [14] who found out that some methacrylic copolymers that contain
(similarly to heparin) sulfate, sulfamic, and carboxylic groups have an anticoagulation effect. Therefore,
the compounds holding some of these functional groups were chosen for the functionalization of neat
PANI films in this work. Dodecylbenzenesulfonic acid sodium salt (SDBS), 2-aminoethane-1-sulfonic
acid (taurine), and N-(2-acetamido)-2-aminoethanesulfonic acid (ACES) were, therefore, chosen as
modifiers with a potential anticoagulation effect.
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2. Materials and Methods
2.1. Sample Preparation
PANI films containing the above-given compounds (Figure 1) were prepared using two different
procedures: (1) By modification of the surfaces of neat PANI films, PANI salt, or PANI base with SDBS,
taurine or ACES, and (2) by adding the respective substance directly into a reaction mixture of aniline
hydrochloride and ammonium peroxydisulfate used for the preparation of PANI.
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(50 mL) of ammonium peroxydisulfate (5.71 g) was added, and the reaction mixture was stirred and
poured over the substrates (polypropylene foil and blood-collection tubes). The reaction was left to
continue for 1 h. The films of PANI salts formed on the substrates containing respective dopants were
then rinsed with 0.2 M HCl and were left to dry in the air. The samples were labelled as PANI-MSDBS
and PANI-MTaurine. Polyaniline powders obtained after polymerization along with the films were
treated similarly and used for conductivity determination.
2.2. Surface Energy Measurement
Contact angle data was obtained with a Surface Energy Evaluation System (Advex Instruments,
Brno, Czech Republic). Deionized water, ethylene glycol, and diiodomethane were utilized as test
liquids. The volume of droplets was set to 5 µL for all experiments to avoid errors connected
with gravity acting on the sessile drop. Five contact angle readings were averaged to obtain one
representative value. The free energy of the film surfaces was determined by the Lifshitz–van der
Waals “acid–base” model. Total surface energy (γtot) was calculated and reported.
2.3. Conductivity
The conductivity of the polyaniline powders collected after polymerization and compressed to
pellets was measured by the four-point van der Pauw method. A programmable electrometer with
an SMU Keithley 237 current source and a Multimeter Keithley 2010 voltmeter (Keithley instrument,
Cleveland, OH, USA) with a 2000 SCAN 10-channel scanner card were employed. Measurements were
carried out at ambient temperature.
2.4. Anticoagulation Test
In all tests, venous blood was collected from healthy donors by venipuncture using the vacuum
blood collection system into the 5 mL collecting tubes (VACUETTE, Greiner Bio-One, Kremsmünster,
Austria) after obtaining informed consent. All tests were conducted in accordance with the Helsinki
Declaration. Plasma was prepared from the venous blood by centrifugation (15 min, 3000× g).
Plasma was subsequently transferred to the blood-collection tubes coated with studied PANI films.
The measurement of coagulation was performed using an instrument commercially used in hospitals,
the SYSMEX CA-1500 (Siemens, Erlangen, Germany). The principle of measurement is based on the
change of turbidity (measured at a wavelength of 660 nm) as a consequence of adding coagulation
reagent which induces the formation of fibrin clothes. In the present study, the following coagulation
parameters in human blood plasma treated with 0.109 M citric were studied: (1) Thrombin clotting
time (TCT), (2) activated partial thromboplastin time (aPTT), and (3) prothrombin time (PT).
3. Results and Discussion
Hemocompatibility is a complex process and its testing by common in-vitro methods is not able to
comprehensively cover all its aspects. Blood coagulation as a whole includes not only the coagulation
cascade but also the platelet adhesion and can be, for example, triggered by various biochemical cues
or blood rheology (flow velocity, flow turbulence, shear stress) [16]. Especially in the case of platelet
adhesion, the shear rates of the fluid are important. In this work, we focused on one of the important
aspects of blood coagulation, namely on the detection of coagulation induced by the surface properties
of modified PANI films. Although the biological properties of PANI in its native or modified form have
already been studied, and cytotoxicity [5], interaction with stem cells [17], or interaction with tissues
have already been reported, another important parameter of biocompatibility, namely interaction with
blood has only been the subject of a few studies. The effect of PANI itself on platelet adhesion, hemolysis
and plasma recalcification time has been studied by Li et al. [18]. Here, PANI-coated polyurethane (PU)
fibers were tested. Platelets on PANI-coated PU demonstrated lower aggregation (6.87 × 105 cm−2)
than platelets on PU fibers without modification (15.63 × 105 cm−2). As regards hemolysis, according
to requirements of ISO 10993-4, materials with hemolysis values <5% are considered safe in contact
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with blood. In the study, PANI-PU fibers exhibited hemolysis values of 0.14% and non-coated PU fibers
0.21%. The tests also showed that PANI prolonged plasma recalcification time by 13 s, improving thus
anticoagulation. The impact of PANI on the blood coagulation can be also improved by modification
of its surface by bioactive substances. For example, a work of Zhang et al. [19] studied modifications
of PANI films with poly(ethylene glycol) (PEG) to reduce the adhesion of proteins and platelets on
its surface. In this case, the PEG chain was covalently bound to PANI film. Adhesion of bovine
serum albumin (BSA) and γ-globulin decreased with increasing concentration of surface-bound PEG.
The same results were obtained for platelet adhesion. Li and Ruckenstein [20] tested BSA and platelet
adhesions on native PANI and poly(ethylene oxide) (PEO) grafted films. Correspondingly to the
previous study, modification of the PANI film with hydrophilic PEO also reduced protein adhesion, in
this case by 80%. Platelet adhesion also decreased significantly. In the case of the unmodified film,
there was adhesion of 18 × 103 mm−2. For the modified film, the adhesion value was 2.1 × 103 mm−2.
Similar results were achieved in work of Humpolicek et al. [11]. This report investigated the impact of
PANI functionalized with PAMPSA on blood coagulation and found out that PANI films reprotonated
with this high-molecular-weight acid hindered blood coagulation by interaction with three of the
coagulation factors: Xa, Va, and IIa. Moreover, PAMPSA-modified PANI also reduced platelet adhesion.
It was generally expected that methacrylic copolymers containing similarly to heparin the sulfate,
sulfamic, and carboxylic groups, may have an anticoagulation effect. With respect to this assumption,
SDBS, taurine, and ACES might have the potential to influence blood compatibility as well. As PANI is
a versatile material that can easily be modified by a variety of methods, the PANI films were prepared
using the above-mentioned substances either by their direct addition into the reaction mixture with
subsequent preparation of films, or by modification of neat PANI-S and PANI-B films via pouring over
the solutions of each of these substances.
The standard polyaniline salt, PANI-S, contains chloride counter-ions (Figure 1A), as well as
sulfate ions originating from the reduction of peroxydisulfate. These counter-ions are removed after
the conversion to PANI-B. After immersion of PANI-B into the solution of, e.g., taurine, immobilization
of this substance onto PANI film takes place resulting in their mutual salt (PANI-BTaurine) containing
corresponding taurine counter-ions. As regards PANI-S films modified with studied heparin-like
substances, it can be assumed that a layer of the respective substance remains on the surface of neat
PANI. When PANI is prepared in the presence of taurine in reaction mixture, PANI-MTaurine, the
films contain chloride, sulfate, and taurine counter-ions. The PANI films prepared in various ways
thus differ in the type and occurrence of counter-ions, or more general in surface chemistry.
Blood coagulation can be triggered by contact with interfaces due to the following three crucial
characteristics/properties of a surface: (1) The surface energy, (2) the acidity (pH), and (3) the interaction
of surfaces with coagulation factors of blood. The adherence of plasma proteins and the subsequent
adherence of platelets and leukocytes are also of importance regarding the plasmatic coagulation,
which again depends on the surface characteristics of the material. The surface energies measured
on modified PANI films were similar for almost all samples (Table 1) and did not differ from γtot
determined on neat PANI-S and PANI-B films [21]. The exception here was PANI-BACES with γtot
equal to 41 ± 1 mN cm−1. For practical application, the stability of the samples is crucial, and the effect
of aging on the surface energy was also determined. The surface energy of all samples was stable for at
least two weeks, except for the PANI-BTaurine and PANI-STaurine films (Table 1).
It is known that the physiological pH of blood lies within a tight range from 7.31 to 7.42 [22],
and several non-physiological reactions can occur as a consequence of the pH changes, including
inhibition and prolongation of coagulation processes. The pH of blood after being in contact with the
samples was therefore determined, and it was unambiguously confirmed that the pH was not notably
influenced by any of the tested samples.
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Table 1. The surface energy of modified PANI surfaces, γtot, determined immediately after preparation,
and after 7 and 14 days on the stored under laboratory conditions. The values are compared with γtot
of neat PANI-S and PANI-B films.
γtot ± SD (mN·m−1)
Day 0 Day 7 Day 14
PANI-BSDBS 51 ± 3 51 ± 2 50 ± 7
PANI-SSDBS 51 ± 3 47 ± 4 44 ± 4
PANI-BTaurine 51 ± 7 53 ± 2 38 ± 12
PANI-STaurine 55 ± 8 45 ± 7 47 ± 2
PANI-BACES 41 ± 1 37 ± 1 45 ± 0
PANI-MSDBS 46 ± 5 47 ± 4 46 ± 4
PANI-MTaurine 53 ± 4 44 ± 10 46 ± 4
PANI-S (a) 52.54 n.d. n.d.
PANI-B (a) 50.88 n.d. n.d.
(a) Reproduced from [21]; n.d. not determined.
Conductivity is another important characteristic of conducting polymers. The standard films of
PANI-S commonly show conductivity within units of S·cm−1 [23]. The conductivity measurements
on fresh samples, and after 7 and 14 days of their storage at room temperature are summarized in
Table 2. A certain conductivity drift is likely to be associated with still decreasing sample humidity.
Measurements revealed that only the samples synthesized with SDBS or taurine present in the
reaction mixture showed reasonably high conductivity and all other films exhibited conductivity lower
than 10−4 S·cm−1. It is beyond the scope of this manuscript to define the relationship between the
conductivity of materials and their applicability in biomedicine. This is a comprehensive issue and the
situation is complicated not only by the fact that conducting polymers combine ionic and electronic
conductivity but also by the different resistivity of various tissues (e.g., from 100 Ω·cm for blood to
1000 Ω·cm for some tissues) [24] which corresponds to the conductivity of 0.01 to 0.001 S·cm−1. In this
context, the conductivity of here-tested PANI samples, especially these where taurine was present in
the reaction mixture, is significantly higher reaching ~18 S·cm−1.
Table 2. The conductivity of bulk PANI (S cm−1) containing the studied substances.
Sample Day 0 Day 7 Day 14
PANI-MSDBS 7.0 ± 0.03 5.7 ± 0.002 5.2 ± 0.004
PANI-MTaurine 17.9 ± 0.01 16.5 ± 0.004 15.8 ± 0.003
The coagulation parameters of the blood after contact with the studied surfaces are presented
in Table 3. The thrombin clotting time (TCT), activated partial thromboplastin time (aPTT), and
prothrombin time (PT) were studied as clinically relevant parameters using the methods described
earlier [11]. Similarly to neat PANI-S and PANI-B [11], none of the PANI modified with SDBS, taurine
or ACES significantly impacted blood coagulation (Table 3), and all the coagulation parameters were
within their respective physiological ranges. The expected impact of taurine, SDBS, or ACES on the
hemocompatibility was not hence confirmed. So far, the only compound suitable for influencing
the hemocompatibility of PANI is, as previously described [11], PAMPSA. Here, an interesting
question arises with regard to the reason why SDBS, taurine, or ACES were not able to modify the
hemocompatibility of PANI even though they contain functional groups similar to PAMPSA.
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Table 3. Impact of PANI with modified surfaces on selected coagulation parameters, prothrombin time
(PT), activated partial thromboplastin time (aPPT), thrombin clotting time (TCT), expressed as times to
the coagulation start.
PT [s] aPPT [s] TCT [s]
Reference 12.1 ± 0.1 25.2 ± 0.5 16.7 ± 0.3
PANI-BSDBS 12.2 ± 0.6 29.5 ± 4.7 20.0 ± 2.2
PANI-SSDBS 11.8 ± 0.2 25.6 ± 0.3 18.3 ± 0.3
PANI-BTaurin 11.8 ± 0.0 25.4 ± 0.5 17.7 ± 0.5
PANI-STaurin 11.8 ± 0.2 26.9 ± 0.6 19.2 ± 0.4
PANI-BACES 12.3 ± 0.0 25.4 ± 0.3 15.4 ± 0.4
PANI-MSDBS 12.0 ± 0.1 25.8 ± 0.6 18.2 ± 0.5
PANI-MTaurin 12.1 ± 0.3 30.0 ± 2.5 19.7 ± 0.6
Note: As reference coagulation parameters of donor blood were used. Normal ranges for coagulation parameters of
a healthy person: PT 11.0–13.5, aPTT 25–32, TCT below 20 s. The values are expressed as mean value ± standard
deviation of three tests.
Based on the results presented in Tables 1–3 and on previously published findings, the reason
for this can be found in the low-molecular-weight character of these substances, which in all three
cases lies below 350 g·mol−1. On the other hand, in the case of hemocompatible PANI-PAMPSA,
its anticoagulation activity can be also assigned to the presence of the high-molecular-weight PAMPSA
polyanion (molar mass ≈ 106 g·mol−1) bound to polycationic PANI surface. During reprotonation,
a fraction of anions on a PAMPSA chain is bound as counter-ions to the PANI backbone. However,
a substantial fraction of the functional sulfo groups still remains free to interact with blood and can act
as an anticoagulant agent. In this context, it can be mentioned that also the best-known anticoagulation
agent, heparin, is a polymer. This polysaccharide consists of chains containing 1,4-bonded residues
of uronic acid and D-glucosamine, and its molar mass ranges from 3000 to 30,000 g·mol−1, with an
average of 15,000 g·mol−1 [25]. However, its anticoagulant activity is closely related to a unique
pentasaccharide sequence necessary for linking to antithrombin [26]. In the heparin chain without this
pentasaccharide sequence, the anticoagulation activity is absent [27].
In summary, the present pilot study covers only a limited part of the complex hemocompatibility
process. The impact of above-mentioned parameters, such as blood flow velocity, flow turbulence,
shear stress, or tension on the hemocompatibility of PANI-based surfaces has not been studied so
far. It, therefore, opens the possibility for further testing of the effect of the low-molecular-weight
substances with sulfo groups on the hemocompatibility, which can be conducted under physiological
flow conditions and using blood flow models.
4. Conclusions
The PANI films modified by substances with anticipated anticoagulant activity, sodium
dodecylbenzenesulfonate (SDBS), 2-aminoethane-1-sulfonic acid (taurine) and N-(2-acetamido)-
2-aminoethanesulfonic acid (ACES) have been studied. The hemocompatibility tests conducted
on these PANI films confirmed that none of them showed anticipated anticoagulation activity, though
the functional groups typical for anticoagulation substances were present. The absence of the activity
can be ascribed to the low molecular weight of these compounds used for PANI modification. It can be,
therefore, concluded that, in addition to the presence of suitable functional groups in the molecule, the
dopants introducing anticoagulation activity should exhibit polymer-like character with sufficiently
high molecular weight.
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